Kristi R Estabrook, Mara Pheister. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAnti-Anxiety Agents/adverse effectsAnti-Anxiety Agents/therapeutic useAntimanic Agents/adverse effectsAntimanic Agents/therapeutic useAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useAnxiety Disorders/complicationsAnxiety Disorders/drug therapyAnxiety Disorders/psychologyBipolar Disorder/complicationsBipolar Disorder/drug therapyBipolar Disorder/psychologyClonazepam/adverse effectsClonazepam/therapeutic useDelayed-Action PreparationsDelusions/complicationsDelusions/drug therapyDelusions/psychologyDibenzothiazepines/adverse effectsDibenzothiazepines/therapeutic useDrug MonitoringDrug Therapy, Combination/adverse effectsHumansMaleMianserin/adverse effectsMianserin/analogs & derivativesMianserin/therapeutic useMirtazapineNeutropenia/chemically inducedPolypharmacyQuetiapine FumarateSuicidal IdeationTreatment OutcomeValproic Acid/adverse effectsValproic Acid/therapeutic use
Substances： See more » Anti-Anxiety AgentsAntimanic AgentsAntipsychotic AgentsDelayed-Action PreparationsDibenzothiazepinesMianserinQuetiapine FumarateClonazepamValproic AcidMirtazapine
Year: 2012 PMID： 22561473 DOI： 10.1097/JCP.0b013e318253a071
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN： 0271-0749 Impact factor: 3.153